Semax 10 mg – Laboratory Research Material
Semax 10 mg – Laboratory Research Material
Tracked shipping from Switzerland
CH CHF 9.50 · approx. 1–2 business days | Europe CHF 17.50 · approx. 2–7 business days | International CHF 40.00 · approx. 5–15 business days
Estimates are after dispatch; customs and local carrier handover may extend delivery. Shipping details · Returns
AVELQOR10 · 10% off / Rabatt · Batch / COA documentation where available · Zahlungsarten im Checkout
Manual bank transfer can be selected during the normal Shopify checkout. Orders are processed after payment has been received and matched to the order.
Research, Specifications & Documentation
Clearly structured product information for laboratory and analytical workflows.
Order & Documentation at a Glance
| Availability | In stock |
| Dispatch | From Switzerland with tracked shipping |
| Launch offer | AVELQOR10 · 10% off · no minimum |
| Documentation | Batch / COA resources where available |
| Payment | Available methods are shown in the live checkout |
Semax 10 mg – Laboratory Research Material
Semax 10 mg is listed as a lyophilized peptide research material for neuropeptide, neurotrophic-factor and analytical laboratory research.
Research-Only Notice
For laboratory research use only. Not for human or animal consumption, administration, medical, cosmetic or household use.
Product Specifications
| Material | Semax |
| Form | Lyophilized laboratory research material |
| Declared content | 10 mg |
| Availability | In stock |
| Intended use | Laboratory and analytical research only |
Reference Identity & Technical Data
| Reference name | Semax |
| CAS Registry Number | 80714-61-0 |
| Reference molecular formula | C37H51N9O10S |
| Reference molecular weight | 813.92 g/mol |
| Reference sequence | Met-Glu-His-Phe-Pro-Gly-Pro |
| Sequence shortening | MEHFPGP |
| Research class | ACTH(4-10)-derived peptide · neuropeptide research |
| Purity / identity | Lot-specific; refer only to documentation attributable to the applicable Avelqor batch |
Reference identifiers describe the named research compound in external technical catalogues and literature. They do not by themselves verify the identity, purity, counterion/salt state or assay of an Avelqor vial; batch-specific Avelqor documentation controls.
Research Overview
The supplied HYBIO Peptide Product Reference Guide (2026) describes Semax as a heptapeptide derived from the ACTH 4-10 fragment and places it in cognitive, nootropic and neuroprotective research.
Mechanistic Research Context
The guide discusses neurotrophic-factor research, including BDNF and synaptic-plasticity pathways. These research directions describe experimental mechanisms and do not establish cognitive, neurological or therapeutic effects for this Avelqor material.
Laboratory Research Areas
- Neuropeptide signalling
- BDNF and neurotrophic-factor research
- Synaptic-plasticity models
- Neuroprotection and cognitive research models
- Analytical peptide characterization
Evidence & Limitations
The guide notes that much of the evidence base originates from Soviet/Russian research and that independent Western replication is more limited. It lists 5 mg and 10 mg lyophilized formats as secondary research forms. This evidence context should accompany any summary of reported findings.
Documentation & Traceability
Batch or lot references and supporting analytical documentation are published only where available and attributable to the relevant material. Documentation should be linked only where attributable to the corresponding material and batch.
COA & Batch Documentation · Quality & Testing
Laboratory Handling & Storage
Keep sealed and protected from direct light under the conditions stated on the final product label. Follow laboratory SOPs and document batch identifiers, receipt dates and storage conditions. No preparation, dosing or administration instructions are provided.
Important Use Restriction
Research use only. Not for human or veterinary use, consumption or administration. No clinical, neurological, cognitive-enhancement or consumer-use claim is made.
Reference basis: supplied HYBIO Peptide Product Reference Guide (2026); source statements have not been independently validated by Avelqor Labs.